14 October 2018 | News
Company awarded for excellence in innovation for Parteck MXP Excipient and modified amino acids.
Merck, the vibrant science and technology company, announced that it has won two CPhI Pharma Awards for innovative products for the pharmaceutical industry. The awards were announced at CPhI’s award gala in Madrid, Spain.
CPhI (Convention on Pharmaceutical Ingredients) Pharma is a global organization that connects people within the pharmaceutical industry and celebrates thinkers, creators and companies breaking new ground. “At Merck, we provide innovations that help our customers advance science and accelerate access to better health for people everywhere,” said Andrew Bulpin, head of Process Solutions, Life Science, at Merck. “We are pleased that CPhI has recognized our commitment to drive the industry forward and empower researchers and scientists with products that improve drug development quality and efficiency.”
The company received the following awards: Parteck® MXP Excipient won for “Excellence in Excipients.” Parteck® MXP excipient is a new polyvinyl alcohol excipient for the formulation of stable amorphous solid dispersions by hot melt extrusion, providing enhanced solubility of active pharmaceutical ingredients (APIs) and stable, high drug loads. The new excipient is applicable for a variety of final formulations with different release kinetics and offers the formulator flexibility in designing a drug product that fits the respective API and desired therapeutic effect.
Merck’s modified amino acids won for “Excellence in Bioprocessing and Manufacturing.” The modified amino acids Phospho-Tyrosine disodium salt and Sulfo-Cysteine sodium salt are components for biomanufacturing and mAb processes, designed to simplify fed batch processes in applying a single-feed strategy.